Considerations for defining medication exposure when analyzing real‐world data

Saved in:
Bibliographic Details
Published in:Pharmacoepidemiology and drug safety Vol. 32; no. 8; pp. 933 - 937
Main Authors: Clary, Alecia, Lin, Nancy D., Lasky, Tamar, Reynolds, Matthew W., Chokkalingam, Anand, Rodriguez‐Watson, Carla
Format: Journal Article
Language:English
Published: Chichester, UK John Wiley & Sons, Inc 01-08-2023
Wiley Subscription Services, Inc
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Lin, Nancy D.
Lasky, Tamar
Clary, Alecia
Chokkalingam, Anand
Rodriguez‐Watson, Carla
Reynolds, Matthew W.
Author_xml – sequence: 1
  givenname: Alecia
  orcidid: 0000-0002-7774-9808
  surname: Clary
  fullname: Clary, Alecia
  email: aclary@reaganudall.org
  organization: The Reagan‐Udall Foundation for the FDA
– sequence: 2
  givenname: Nancy D.
  surname: Lin
  fullname: Lin, Nancy D.
  organization: IQVIA Real World Solutions
– sequence: 3
  givenname: Tamar
  orcidid: 0000-0003-4104-394X
  surname: Lasky
  fullname: Lasky, Tamar
  organization: The United States Food and Drug Administration, Office of Data, Analytics, & Research, Office of the Commissioner
– sequence: 4
  givenname: Matthew W.
  surname: Reynolds
  fullname: Reynolds, Matthew W.
  organization: IQVIA Real‐World Solutions
– sequence: 5
  givenname: Anand
  surname: Chokkalingam
  fullname: Chokkalingam, Anand
  organization: Gilead Sciences
– sequence: 6
  givenname: Carla
  surname: Rodriguez‐Watson
  fullname: Rodriguez‐Watson, Carla
  organization: The Reagan‐Udall Foundation for the FDA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36929112$$D View this record in MEDLINE/PubMed
BookMark eNp1kMtKw0AUQAep2FYFv0ACbtyk3nk2s5T6hIIFdR0mk4lOSTN1pqHWlZ_gN_olJm1VEFzdC_dw4J4-6lSuMggdYRhgAHI2z8OAC0x3UA-DlDHmfNhpd07jhAvZRf0QpgDNTbI91KVCEokx6aHJyFXB5sarhW22qHA-yk1hK1s9RTOTW70-ROZ17kLtTbR8NlWkKlWu3lrEG1V-vn8snS_zKFcLdYB2C1UGc7id--jx6vJhdBOP765vR-fjWFPGaKy1VDIrMqYKmQicyMIwoFqTAsQwIxQEEMphyPJM4gwE4wxyTTA3mDOugO6j04137t1LbcIindmgTVmqyrg6pCQBKoVglDToyR906mrfvNBSlCaCU6C_Qu1dCN4U6dzbmfKrFEPaVk6bymlbuUGPt8I6axr9gN9ZGyDeAEtbmtW_onRycb8WfgHDiIfI
Cites_doi 10.1177/1474651411422825
10.1007/s10916-009-9278-5
10.1093/jamia/ocv202
10.1002/pds.4372
10.1093/jamia/ocv054
10.1002/pds.5372
10.1001/jamanetworkopen.2022.50423
10.1016/j.jval.2017.08.3019
10.1016/j.jclinepi.2009.07.001
ContentType Journal Article
Copyright 2023 Reagan‐Udall Foundation for the FDA. published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 Reagan‐Udall Foundation for the FDA. published by John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
NPM
AAYXX
CITATION
7TK
K9.
7X8
DOI 10.1002/pds.5613
DatabaseName Wiley-Blackwell Titles (Open access)
Wiley Online Library Free Content
PubMed
CrossRef
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1099-1557
EndPage 937
ExternalDocumentID 10_1002_pds_5613
36929112
PDS5613
Genre commentary
Journal Article
GrantInformation_xml – fundername: Food and Drug Administration (FDA) of the U.S. Department of Health and Human Services (HHS)
– fundername: FDA HHS
  grantid: U01 FD007223
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
24P
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GWYGA
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WWP
WXI
WXSBR
XG1
XV2
YCJ
ZZTAW
~IA
~WT
NPM
AAMNL
AAYXX
CITATION
7TK
K9.
7X8
ID FETCH-LOGICAL-c3443-cc9a9bfb4af986189fe403cc2f067b23060235074db91b064540dc215e1545a03
IEDL.DBID 33P
ISSN 1053-8569
IngestDate Sat Aug 17 00:54:39 EDT 2024
Thu Oct 10 17:42:31 EDT 2024
Thu Nov 21 21:40:15 EST 2024
Sat Sep 28 08:10:07 EDT 2024
Sat Aug 24 00:53:40 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License Attribution-NonCommercial
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3443-cc9a9bfb4af986189fe403cc2f067b23060235074db91b064540dc215e1545a03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4104-394X
0000-0002-7774-9808
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.5613
PMID 36929112
PQID 2833865303
PQPubID 105383
PageCount 5
ParticipantIDs proquest_miscellaneous_2803966432
proquest_journals_2833865303
crossref_primary_10_1002_pds_5613
pubmed_primary_36929112
wiley_primary_10_1002_pds_5613_PDS5613
PublicationCentury 2000
PublicationDate August 2023
2023-Aug
2023-08-00
20230801
PublicationDateYYYYMMDD 2023-08-01
PublicationDate_xml – month: 08
  year: 2023
  text: August 2023
PublicationDecade 2020
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: Bethesda
PublicationTitle Pharmacoepidemiology and drug safety
PublicationTitleAlternate Pharmacoepidemiol Drug Saf
PublicationYear 2023
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2010; 34
2017; 20
2011; 11
2018; k3532
2022; 31
2022
2023; 6
2021; m4856
2018; 27
2010; 63
2016; 23
2015; 22
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_7_1
e_1_2_7_2_1
e_1_2_7_15_1
Wang SV (e_1_2_7_12_1) 2021; 4856
e_1_2_7_13_1
e_1_2_7_11_1
e_1_2_7_10_1
Langan SM (e_1_2_7_14_1) 2018; 3532
References_xml – volume: 6
  year: 2023
  article-title: Trends and characteristics of potentially preventable emergency department visits among patients with cancer in the US
  publication-title: JAMA Netw Open Am Med Assoc
– volume: 27
  start-page: 148
  year: 2018
  end-page: 160
  article-title: Methods for time‐varying exposure related problems in pharmacoepidemiology: an overview
  publication-title: Pharmacoepidemiol Drug Saf
– volume: 22
  start-page: 957
  year: 2015
  end-page: 961
  article-title: An algorithm to identify medication nonpersistence using electronic pharmacy databases
  publication-title: J Am Med Inform Assoc
– volume: 23
  year: 2016
  article-title: PheKB: a catalog and workflow for creating electronic phenotype algorithms for transportability
  publication-title: J Am Med Inform Assoc
– volume: 63
  start-page: 422
  year: 2010
  end-page: 427
  article-title: Construction of drug treatment episodes from drug‐dispensing histories is influenced by the gap length
  publication-title: J Clin Epidemiol
– volume: m4856
  start-page: 372
  year: 2021
  article-title: STaRT‐RWE: structured template for planning and reporting on the implementation of real world evidence studies
  publication-title: Br Med J
– volume: k3532
  start-page: 363
  year: 2018
  article-title: The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD‐PE)
  publication-title: Br Med J
– volume: 11
  start-page: 304
  year: 2011
  end-page: 307
  article-title: The European network of Centres for pharmacoepidemiology and pharmacovigilance: application to diabetes and vascular disease
  publication-title: Br J Diab Vasc Dis
– volume: 20
  start-page: 1003
  year: 2017
  end-page: 1008
  article-title: Good practices for real‐world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR‐ISPE special task force on real‐world evidence in health care decision making
  publication-title: Value Health
– volume: 31
  start-page: 13
  year: 2022
  end-page: 21
  article-title: A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies
  publication-title: Pharmacoepidemiol Drug Saf
– year: 2022
– volume: 34
  start-page: 651
  year: 2010
  end-page: 657
  article-title: Achieving standardized medication data in clinical research studies: two approaches and applications for implementing RxNorm
  publication-title: J Med Syst
– ident: e_1_2_7_5_1
– ident: e_1_2_7_15_1
  doi: 10.1177/1474651411422825
– ident: e_1_2_7_2_1
  doi: 10.1007/s10916-009-9278-5
– ident: e_1_2_7_3_1
  doi: 10.1093/jamia/ocv202
– ident: e_1_2_7_9_1
  doi: 10.1002/pds.4372
– volume: 3532
  start-page: 363
  year: 2018
  ident: e_1_2_7_14_1
  article-title: The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD‐PE)
  publication-title: Br Med J
  contributor:
    fullname: Langan SM
– ident: e_1_2_7_11_1
  doi: 10.1093/jamia/ocv054
– ident: e_1_2_7_6_1
– ident: e_1_2_7_8_1
  doi: 10.1002/pds.5372
– ident: e_1_2_7_4_1
– ident: e_1_2_7_7_1
  doi: 10.1001/jamanetworkopen.2022.50423
– volume: 4856
  start-page: 372
  year: 2021
  ident: e_1_2_7_12_1
  article-title: STaRT‐RWE: structured template for planning and reporting on the implementation of real world evidence studies
  publication-title: Br Med J
  contributor:
    fullname: Wang SV
– ident: e_1_2_7_13_1
  doi: 10.1016/j.jval.2017.08.3019
– ident: e_1_2_7_10_1
  doi: 10.1016/j.jclinepi.2009.07.001
SSID ssj0009994
Score 2.4254115
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 933
Title Considerations for defining medication exposure when analyzing real‐world data
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpds.5613
https://www.ncbi.nlm.nih.gov/pubmed/36929112
https://www.proquest.com/docview/2833865303
https://search.proquest.com/docview/2803966432
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV27TsMwFLWgEwvvR6AgI6FODU3jJLXZELTqhCK1SGyR7ThiQGlFqKBMfALfyJdwr9M0qhASElMGO3Hk6-tz_LjnEnKRam6E6hpwJMncgGWhKwGmXQPQIINQA-JgNPJw1Lt74Ld9lMm5qmJhSn2I5YYbeoadr9HBpSo6tWjoNC0ukf3C9AuLBBu9weJab1fYHIjAHpjLw0hUurOe36leXEWiH_Ryla1auBls_edHt8nmgmTS63JU7JA1k--SVlyqVM_bdFwHXRVt2qJxrV893yNxlcSz3MyjQGtpajKbSYLas3hbQM3bdIL7i_T10eRUorrJO1YBGvr09fFptVgp3kDdJ_eD_vhm6C4SL7iaBQFztRZSqEwFMhM86nKRmcBjWvsZYJvCRQuq5AD5SJXoKlS8C7xUA3kwSMikxw5II5_k5ohQ7qWekkYBz4Ii7fNIsVBpr-fzTAvOHXJeGSGZlvoaSamk7CfQcQl2nEOalXWShYcVCdAiTFcKCAyfWBaDb-CBh8zNZIZ1PAbLuYD5DjksrbpshEVADIFsOqRljfdr60l8O8Ln8V8rnpANzElf3hJsksbL88yckvUinZ3ZMfoNUp3pYQ
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JT_MwEB2xHODC-gFlNRLqiXyksRtscUIsKmJRJIrELbIdRxxQWlEqlhM_gd_IL2HGaVohhITEKQc7ceTx5L2MPW8AdjIrnTINh46keSB43gw0wnTgEBq0aFpEHMpGbl3vX93K4xOSyTmocmFKfYhhwI08w3-vycEpIL03Ug3tZr3_RH_HYVLEuA4pf4MnI8Vd5asgIn_ggWzGqlKeDaO96s6vWPSNYH7lqx5wTmf_9KpzMDPgmeywXBjzMOaKBagnpVD1yy5rj_KueruszpKRhPXLIiRVHc8ynseQ2bLM5b6YBPPb8b6Bueduh0KM7OnOFUyTwMkrdUEmev_x9u7lWBkdQv0HN6cn7aNWMKi9EFguBA-sVVqZ3AidKxk3pMqdCLm1UY7wZui_hYRykH9kRjUMid6JMLPIHxxxMh3yJZgoOoVbASbDLDTaGaRa2GQjGRveNDbcj2RulZQ12K6skHZLiY20FFOOUpy4lCauBuuVedKBk_VSZEZUsRRBGB8xbEb3oD0PXbhOn_qEHP_oBI9qsFyadTgIj5EbIt-sQd1b78fR0-T4mq6rv-24BVOt9uVFenF2db4G01Sivjw0uA4Tjw99twHjvay_6RfsJxAN7Yk
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ1bS8MwFMcPXkB88X6Z1wiyJ6tdk83EN3EORRkFFXwrSZrig3TDObw8-RH8jH4Sz0nXjSGC4FMfkjYlJ6fn11z-B2A_tdIpU3PoSJoHgmf1QGOYDhyGBi3qFiMOnUa-uDlu38vmOcnknJRnYQp9iOGEG3mG_16Tg3fT7GgkGtpNe4dEv5MwLZDCSTef83gkuKt8EkTEBx7IekOVwrNhdFTeOR6KfvDlOK76eNOa_8-bLsDcgDLZaTEsFmHC5UtQjQuZ6rcDdjs6ddU7YFUWjwSs35YhLrN4FrN5DLmWpS7zqSSYX4z3Bcy9djs0wcheHlzONMmbvFMV5NDHr49PL8bKaAvqCty1zm_PLoJB5oXAciF4YK3SymRG6EzJRk2qzImQWxtlGNwM_bWQTA7SR2pUzZDknQhTi_TgiMh0yFdhKu_kbh2YDNPQaGcQtLDIRrJheN3Y8DiSmVVSVmCvNELSLQQ2kkJKOUqw4xLquApsldZJBi7WS5CLKF8phmB8xLAYnYNWPHTuOn2qE3L8nxM8qsBaYdVhI7yBZIi0WYGqN96vrSdx84auG3-tuAszcbOVXF-2rzZhlvLTFzsGt2Dq-anvtmGyl_Z3_HD9BkEQ7C8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Considerations+for+defining+medication+exposure+when+analyzing+real%E2%80%90world+data&rft.jtitle=Pharmacoepidemiology+and+drug+safety&rft.au=Clary%2C+Alecia&rft.au=Lin%2C+Nancy+D.&rft.au=Lasky%2C+Tamar&rft.au=Reynolds%2C+Matthew+W.&rft.date=2023-08-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=1053-8569&rft.eissn=1099-1557&rft.volume=32&rft.issue=8&rft.spage=933&rft.epage=937&rft_id=info:doi/10.1002%2Fpds.5613&rft.externalDBID=10.1002%252Fpds.5613&rft.externalDocID=PDS5613
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-8569&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-8569&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-8569&client=summon